Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jul 2026 for Werewolf Therapeutics, Inc., €24k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
UBS Oncology Impact Fund, L.P.: trading record in brief
This profile gathers the share dealings of UBS Oncology Impact Fund, L.P. in Werewolf Therapeutics, Inc. In total, 2 filings cover trades dated from 29 June 2026 to 6 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 6 July 2026, the filings show a transaction worth €24k in Werewolf Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to UBS Oncology Impact Fund, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
80,142 shares@ US$0.34040.056% mcap49.0% of flowCommonSEC144:0001628280-26-047364
87,916 shares@ US$0.3230.059% mcap51.0% of flowCommonSEC144:0001628280-26-046084
2 of 2 declarations
